-+ 0.00%
-+ 0.00%
-+ 0.00%

ADMA Biologics FY2025 Revenue expected to be more than $500.00M vs $495.10M Est

Benzinga·05/07/2025 20:15:49
Listen to the news
ADMA Biologics (NASDAQ:ADMA) FY2025 Revenue expected to be more than $500.00M vs $495.10M Est